Contact information Verified work emails, personal emails, and direct dials — unlocked in one click.
Work email
•••••@regrow.in
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••
Free to start · No credit card required
Current company Regrow Biosciences
Biotechnology Research · 125 employees · Founded 2009 · Andheri East Mumbai, Maharashtra, India
Driven by passion, strong business ethics and commitment, Regrow Biosciences Pvt Ltd was established with a Vision to become the world's largest stem cell based tissue and organ development factory. Today, Regrow is India’s leading biotech company pioneering in the field of regenerative medicine having built a platform technology for cell based products.
Regrow Biosciences has also been immensely successful in establishing premium cord blood stem cell bank; Biocell™ (formerly known as Babycell™) with patronage of more than 47000 happy parents.
Our Mission remains focused to improving human healthcare by innovating and delivering regenerative medicine based solutions.
Our Journey
• Strong Pillars
Our story began in 2009, when the experience of CEO Mr. Yash Sanghavi, Promoter of Satyan Pharmaceuticals Pvt Ltd (estd 1984) and the passion of his son, Mr. Satyen Sanghavi (Post Graduate Stem Cell Technology from University of Nottingham, UK) combined to result in creation of “Regrow”.
Regrow’s RnD & GMP certified facility was set up in Lonavala (Pune) & now operates with a team of more than 30 life sciences & biotech postgraduates.
• INNOVATIVEfficiency
Regrow is continually cultivating an ecosystem by developing relationship with stakeholders including patients, physicians, hospitals & supply chain partners to deliver quality products targeted for diseases with unmet need.
Educating the society about the benefits of “Cure vs Manage” through use of the most advanced & cutting edge medical treatments using cell therapy.
Contributing to nation building by aligning the corporate strategy to Make In India.
• Dream Big
Aspiring to lead the cell & gene therapy sector, Regrow has successfully established technological prowess on the global platform by receiving the recognition from USFDA (United States) & EMA (Europe) for its Bone Cell Therapy product (Ossgrow®).